Interaction of Coronavirus Disease 2019 with other Infectious and Systemic Diseases
Herausgeber: Qidwai, M Tabish
Interaction of Coronavirus Disease 2019 with other Infectious and Systemic Diseases
Herausgeber: Qidwai, M Tabish
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
The proposed book discuses most recent developments in COVID-19 pathogenesis and treatment. It addresses COVID-19 coinfection with other infectious diseases like malaria and tuberculosis and cancer and focuses on post-COVID and long-term COVID problems.
Andere Kunden interessierten sich auch für
- Peter Lydyard (Royal Free & UK Univ. College Medical School)Case Studies in Infectious Disease68,99 €
- Microbiology of Green Fuels232,99 €
- Bolin Kumar KonwarBacterial Biopolymers154,99 €
- John MattickRNA, the Epicenter of Genetic Information93,99 €
- John MattickRna, the Epicenter of Genetic Information130,99 €
- Sarah SchwitallaThe Toxic Microbiome41,99 €
- von Csefalvay, Chris, MA (Oxon) BCL FRSPH (Vice-President for SpeciaComputational Modeling of Infectious Disease143,99 €
-
-
-
The proposed book discuses most recent developments in COVID-19 pathogenesis and treatment. It addresses COVID-19 coinfection with other infectious diseases like malaria and tuberculosis and cancer and focuses on post-COVID and long-term COVID problems.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis Ltd
- Seitenzahl: 200
- Erscheinungstermin: 29. Juli 2023
- Englisch
- Abmessung: 229mm x 152mm x 14mm
- Gewicht: 482g
- ISBN-13: 9781032350165
- ISBN-10: 1032350164
- Artikelnr.: 68101974
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
- Verlag: Taylor & Francis Ltd
- Seitenzahl: 200
- Erscheinungstermin: 29. Juli 2023
- Englisch
- Abmessung: 229mm x 152mm x 14mm
- Gewicht: 482g
- ISBN-13: 9781032350165
- ISBN-10: 1032350164
- Artikelnr.: 68101974
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
M. Tabish Qidwai is M. Tech and PhD graduate of the Biotechnology Engineering at the Dr. A.P.J. Abdul Kalam Technical University Lucknow, India, and an Associate Professor in the SRM University, UP, India. He previously worked as officiating Director of IBST, SRM University, Assistant Professor at BB Ambedkar University, Lucknow. He is working in the area of infectious disease since more than one decade. He is working as section editor of Current Indian Science (Bentham Science). He has been awarded with several prestigious awards and appreciation letters.
Part I: Current Trends in Pathophysiology and Post COVID Effects. 1. Pathophysiology of SARS-CoV-2 Tejal Shreeya
Tabish Qidwai
and Bhartendu Nath Mishra. 2. Investigation of Post COVID/Long COVID Complications in Humans Sukanya Tripathy
Sanjay Singh
Monisha Banerjee
and Anand Prakash. PART II: Sars Co-V2 Co-Infection with other Pathogens. 3. Falciparum malaria and COVID-19 co-infections AashnaSrivastava
Tabish Qidwai
and Mariam Imam . 4. Interaction of COVID-19 and Tuberculosis Malti Dadheech and Anand Kumar Maurya. 5. Co-Infection of SARS-CoV-2 with Viruses Causing Respiratory and Systemic Infections Sabiha Fatima
Samina Wasi
Nikhat Jamal Siddiqi
and Reem Hamoud Alrashoudi. Part III: Covid-19 and Neurological Complications. 6. Neurological Association of COVID-19 and Neurodegenerative Disorders Shilpa Kumari
Ankit Madeshiya
and Sarika Singh. PART IV: COVID-19 and Cancer. 7. Impact of COVID-19 on Cancer Care
Prognosis
and Immuno-Oncological Challenge of COVID-19 Atar Singh Kushwah
Shireen Masood
Amreen Shamsad
and Monisha Banerjee. 8. Investigating the Severity of COVID-19 in Lung Cancer Patients and Current Treatment: Evidence and Challenges Saurabh Kumar
Osaid Masood
Shama Parveen
Sanjay Saini
and Monisha Banerjee. Part V: Current Therapeutic Approaches. 9. COVID-19 Therapy: Molecular Mechanisms
Pharmacological Interventions
and Therapeutic Targets Ruchi Chawla
Mohini Mishra
Krishan Kumar
and Varsha Rani. 10. Exploration of Nanotherapeutics in COVID-19 Nikhat J. Siddiqi
Sabiha Fathima
Sooad K. AlDaihan
Hanan A. Balto
and Bechan Sharma. 11. Pharmacogenomics and COVID-19 Rishabh Chaudhary
Divya Chaudhary
and Vikas Mishra.
Tabish Qidwai
and Bhartendu Nath Mishra. 2. Investigation of Post COVID/Long COVID Complications in Humans Sukanya Tripathy
Sanjay Singh
Monisha Banerjee
and Anand Prakash. PART II: Sars Co-V2 Co-Infection with other Pathogens. 3. Falciparum malaria and COVID-19 co-infections AashnaSrivastava
Tabish Qidwai
and Mariam Imam . 4. Interaction of COVID-19 and Tuberculosis Malti Dadheech and Anand Kumar Maurya. 5. Co-Infection of SARS-CoV-2 with Viruses Causing Respiratory and Systemic Infections Sabiha Fatima
Samina Wasi
Nikhat Jamal Siddiqi
and Reem Hamoud Alrashoudi. Part III: Covid-19 and Neurological Complications. 6. Neurological Association of COVID-19 and Neurodegenerative Disorders Shilpa Kumari
Ankit Madeshiya
and Sarika Singh. PART IV: COVID-19 and Cancer. 7. Impact of COVID-19 on Cancer Care
Prognosis
and Immuno-Oncological Challenge of COVID-19 Atar Singh Kushwah
Shireen Masood
Amreen Shamsad
and Monisha Banerjee. 8. Investigating the Severity of COVID-19 in Lung Cancer Patients and Current Treatment: Evidence and Challenges Saurabh Kumar
Osaid Masood
Shama Parveen
Sanjay Saini
and Monisha Banerjee. Part V: Current Therapeutic Approaches. 9. COVID-19 Therapy: Molecular Mechanisms
Pharmacological Interventions
and Therapeutic Targets Ruchi Chawla
Mohini Mishra
Krishan Kumar
and Varsha Rani. 10. Exploration of Nanotherapeutics in COVID-19 Nikhat J. Siddiqi
Sabiha Fathima
Sooad K. AlDaihan
Hanan A. Balto
and Bechan Sharma. 11. Pharmacogenomics and COVID-19 Rishabh Chaudhary
Divya Chaudhary
and Vikas Mishra.
Part I: Current Trends in Pathophysiology and Post COVID Effects. 1. Pathophysiology of SARS-CoV-2 Tejal Shreeya
Tabish Qidwai
and Bhartendu Nath Mishra. 2. Investigation of Post COVID/Long COVID Complications in Humans Sukanya Tripathy
Sanjay Singh
Monisha Banerjee
and Anand Prakash. PART II: Sars Co-V2 Co-Infection with other Pathogens. 3. Falciparum malaria and COVID-19 co-infections AashnaSrivastava
Tabish Qidwai
and Mariam Imam . 4. Interaction of COVID-19 and Tuberculosis Malti Dadheech and Anand Kumar Maurya. 5. Co-Infection of SARS-CoV-2 with Viruses Causing Respiratory and Systemic Infections Sabiha Fatima
Samina Wasi
Nikhat Jamal Siddiqi
and Reem Hamoud Alrashoudi. Part III: Covid-19 and Neurological Complications. 6. Neurological Association of COVID-19 and Neurodegenerative Disorders Shilpa Kumari
Ankit Madeshiya
and Sarika Singh. PART IV: COVID-19 and Cancer. 7. Impact of COVID-19 on Cancer Care
Prognosis
and Immuno-Oncological Challenge of COVID-19 Atar Singh Kushwah
Shireen Masood
Amreen Shamsad
and Monisha Banerjee. 8. Investigating the Severity of COVID-19 in Lung Cancer Patients and Current Treatment: Evidence and Challenges Saurabh Kumar
Osaid Masood
Shama Parveen
Sanjay Saini
and Monisha Banerjee. Part V: Current Therapeutic Approaches. 9. COVID-19 Therapy: Molecular Mechanisms
Pharmacological Interventions
and Therapeutic Targets Ruchi Chawla
Mohini Mishra
Krishan Kumar
and Varsha Rani. 10. Exploration of Nanotherapeutics in COVID-19 Nikhat J. Siddiqi
Sabiha Fathima
Sooad K. AlDaihan
Hanan A. Balto
and Bechan Sharma. 11. Pharmacogenomics and COVID-19 Rishabh Chaudhary
Divya Chaudhary
and Vikas Mishra.
Tabish Qidwai
and Bhartendu Nath Mishra. 2. Investigation of Post COVID/Long COVID Complications in Humans Sukanya Tripathy
Sanjay Singh
Monisha Banerjee
and Anand Prakash. PART II: Sars Co-V2 Co-Infection with other Pathogens. 3. Falciparum malaria and COVID-19 co-infections AashnaSrivastava
Tabish Qidwai
and Mariam Imam . 4. Interaction of COVID-19 and Tuberculosis Malti Dadheech and Anand Kumar Maurya. 5. Co-Infection of SARS-CoV-2 with Viruses Causing Respiratory and Systemic Infections Sabiha Fatima
Samina Wasi
Nikhat Jamal Siddiqi
and Reem Hamoud Alrashoudi. Part III: Covid-19 and Neurological Complications. 6. Neurological Association of COVID-19 and Neurodegenerative Disorders Shilpa Kumari
Ankit Madeshiya
and Sarika Singh. PART IV: COVID-19 and Cancer. 7. Impact of COVID-19 on Cancer Care
Prognosis
and Immuno-Oncological Challenge of COVID-19 Atar Singh Kushwah
Shireen Masood
Amreen Shamsad
and Monisha Banerjee. 8. Investigating the Severity of COVID-19 in Lung Cancer Patients and Current Treatment: Evidence and Challenges Saurabh Kumar
Osaid Masood
Shama Parveen
Sanjay Saini
and Monisha Banerjee. Part V: Current Therapeutic Approaches. 9. COVID-19 Therapy: Molecular Mechanisms
Pharmacological Interventions
and Therapeutic Targets Ruchi Chawla
Mohini Mishra
Krishan Kumar
and Varsha Rani. 10. Exploration of Nanotherapeutics in COVID-19 Nikhat J. Siddiqi
Sabiha Fathima
Sooad K. AlDaihan
Hanan A. Balto
and Bechan Sharma. 11. Pharmacogenomics and COVID-19 Rishabh Chaudhary
Divya Chaudhary
and Vikas Mishra.